Platinum Sponsors
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. We work to provide hope for people whose lives are impacted by rare liver diseases, such as Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), a rare growth disorder or rare bone disease. To us, it’s important we put the person living with rare disease first in all that we do. Every day, our more than 5,000 employees worldwide, including nearly 800 in North America, work diligently to improve lives around the world.
Mirum Pharmaceuticals is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines deep rare disease expertise with strong connections to patient communities. The company’s commercial portfolio includes LIVMARLI® (maralixibat) for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile-acid synthesis disorders, and CTEXLI® (chenodiol) for cerebrotendinous xanthomatosis (CTX).
Mirum’s clinical-stage pipeline includes volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), brelovitug, a fully human monoclonal antibody in late-stage development for chronic hepatitis delta virus (HDV), and MRM-3379, a PDE4D inhibitor being evaluated for Fragile X syndrome (FXS).
Mirum’s success is driven by a team dedicated to advancing high impact medicines through strategic development, disciplined execution and purposeful collaboration across the rare disease ecosystem.
Gold Sponsor
Silver Sponsor
Bridge to Life, with a strong focus on product quality and accessibility, is advancing the mission of saving lives with innovative solutions —including gold standard Belzer UW® Solutions and the cost-effective, easy-to-use VitaSmart™ Hypothermic Oxygenated Perfusion system—designed to improve organ viability, enhance recipient outcomes, and optimize transplant success.
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 5,384+ peer-reviewed publications and 218+ international guidelines.
Bringing more to parenteral nutrition (PN): As the US market leader in lipid injectable emulsions (ILEs),1 Fresenius Kabi offers more options, more choices, and more variety to nourish critically or chronically ill patients of any age—from hospital to home.
Bronze Sponsor
Developing cellular biomarkers for personalized diagnosis and drug development in infectious diseases, solid organ transplantation, as well as immunological disorders.
Grants
Veloxis provided a medical education grant to SPLIT 2026.
Centers of Excellence
Leading pediatric hospital offering liver and multi-organ transplant care in Central Florida.
Lurie has performed 500+ pediatric liver transplants and leads the Great Lakes region. Their program includes advanced techniques like split/reduced-size and living donor transplants.
Here, it’s different.
The Liver Transplant Program at Children’s Hospital Colorado offers a unique and specialized program devoted to the care of children who require liver transplantation. Our unique multidisciplinary team cares for kids and families from the time of diagnosis to transplant and all the way through long-term post-transplant care. We achieve some of the best outcomes in the nation by working with every medical and surgical specialty in the hospital to reimagine children’s lives.
World-renowned children’s hospital with extensive transplant research and services.
The Brendan Tripp Elam Transplant Center at Children’s Mercy Kansas City offers pediatric heart, liver, kidney, and multi-organ transplants. It includes a Level I pediatric trauma center and a nationally recognized NICU, with over 8,400 employees and more than 50 specialties.
The Pediatric Liver Transplant team at Children’s of Alabama has collaborated with the University of Alabama at Birmingham (UAB) transplant services since 1993 and has performed 150 liver transplants. The Pediatric Transplant Center at Children’s of Alabama was opened in March 2013 at the Benjamin Russell Hospital for Children. Our patients are cared for by a skilled, multidisciplinary team including UAB surgeons, pediatric gastroenterologists, hepatology services, liver transplant coordinators, and other specialists in our transplant program. Our team coordinates all aspects of care during the evaluation phase, transplantation, and post-procedure care to ensure positive outcomes.
Since 1911, Children’s of Alabama has provided specialized medical care for ill and injured children. Children’s of Alabama is the only medical center in Alabama dedicated solely to the care and treatment of children. It is a private, not-for-profit medical center that serves as the teaching hospital for the UAB pediatric medicine, surgery, psychiatry, research and residency programs.
Children’s Wisconsin has been a pioneer in pediatric heart, liver, kidney and bone marrow transplants for over three decades, helping hundreds of children with end-stage diseases survive and thrive. They offer many family support services including an Access Center, Child Life Services, and a Family Resource Center.
Cincinnati Children's is a nonprofit pediatric health system, consistently ranked among America's best hospitals and a top recipient of NIH pediatric research funding.
University of Michigan’s children’s hospital with strong transplant expertise.
Nemours is one of the largest multistate pediatric systems, with two children's hospitals and 70+ care practices, focusing on holistic, high-quality child health.
Phoenix Children’s is Arizona’s only freestanding comprehensive pediatric hospital, and has grown to become one of the largest children’s hospitals in the United States. With a medical staff of nearly 1,000 pediatric specialists, Phoenix Children’s provides inpatient, outpatient, trauma and emergency care across more than 70 pediatric subspecialties, the most comprehensive pediatric care available in the state.
The pediatric liver transplant program at Phoenix Children’s provides an invaluable resource to the state of Arizona and the local community as the only pediatric liver transplant program in Arizona. The program uniquely integrates a multidisciplinary liver transplant team approach that is equipped to meet the needs of every child at each stage of development. In addition to pediatric transplant physicians and transplant surgeons, the team includes specialists in child life, social work, nutrition, pharmacology, and transplant nursing coordination to ensure continuous care and management of patients through every period of a successful liver transplant.
Utah’s major pediatric transplant center, affiliated with the University of Utah.
Since 1985, St. Louis Children’s has performed over 400 liver transplants including dual-organ and split-liver procedures, with a strong living donor program.
With 50+ years of transplant experience, Stanford leads in combined heart-liver and other multi-organ pediatric transplants, and is #1 nationally in pediatric kidney transplant volume.
Texas Children’s leads the U.S. in liver transplants by volume and complexity, having performed nearly 800 since 1988 and accepting more organ offers than any other program.
Life Changing Medicine
As a nationally recognized center of excellence for pediatric transplantation, UPMC is a leader in pediatric liver transplant specializing in living donor transplant as well as transplants for those with metabolic diseases. Our pediatric hepatology and transplant services are always available for consultation. Pediatric transplant hepatology and transplant surgical fellowship training is offered by our teams. UPMC also directs a pediatric liver transplant network in collaboration with UVA Charlottesville, Advent Health Orlando and Atrium Health Charlotte, N.C.
Non-Profit
ALF’s mission is to promote education, advocacy, support services and research for the prevention, treatment and cure of liver disease.
Make-A-Wish® is a transformative charity serving communities across the globe. Together with supporters, we create life-changing wishes for children with critical illnesses, granting wishes that can positively impact their mental and physical state. Visit our booth or wish.org to find out how you can Share the Power of a Wish®.
Patient Advocacy
At ALGSA, we lead with purpose and heart—delivering vital support, trusted resources, and a strong sense of community to those facing this complex, rare genetic disorder. Our commitment is grounded in improving the lives of ALGS patients and their loved ones through collaboration, education, and empowerment. We are deeply engaged in science and research, working tirelessly to drive initiatives that uncover real answers, improve treatments, and ultimately lead to a cure. Through our research network and programs, we bring together all key stakeholders—physicians, scientists and researchers, biotech and pharmaceutical companies, patients and families, and other nonprofits facing similar medical challenges—to advance knowledge, fill critical gaps, and keep the patient voice front and center.
BARE was created to help solve some of the deficiencies and frustrations that currently exist in the Biliary Atresia community. We believe creating an organization dedicated solely to Biliary Atresia, will help push for progress in finding a cause, treatment, and one day, a cure.